BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9211659)

  • 1. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
    Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
    Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
    Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
    Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism and excretion of 14C-labelled enantiomers of the calcium channel blocker benidipine after oral administration to rat.
    Kobayashi H; Kobayashi S
    Xenobiotica; 1998 Feb; 28(2):179-97. PubMed ID: 9522442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog.
    Pellegatti M; Grossi P; Ayrton J; Evans GL; Harker AJ
    Xenobiotica; 1990 Aug; 20(8):765-77. PubMed ID: 2219960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
    Darwish M; Nunez R; Youakim JM; Robertson P
    Clin Drug Investig; 2024 Jan; 44(1):21-33. PubMed ID: 38017349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and excretion after oral administration of 14C-benidipine hydrochloride in rats and dogs.
    Kobayashi H; Ohishi T; Nishiie H; Kobayashi S; Inoue A; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1742-6. PubMed ID: 3219152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.
    Reif S; Schultze-Mosgau MH; Engelen A; Piel I; Denner K; Roffel A; Tiessen R; Klein S; Francke K; Rottmann A
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):71-85. PubMed ID: 38044419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, metabolism and excretion of tamsulosin hydrochloride in man.
    Soeishi Y; Matsushima H; Watanabe T; Higuchi S; Cornelissen K; Ward J
    Xenobiotica; 1996 Jun; 26(6):637-45. PubMed ID: 8810034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog.
    Naitoh T; Mishima M; Kawaguchi S; Matsui K; Andoh T; Kagei K; Kakiki M; Yuzuriha T; Horie T
    Xenobiotica; 1997 Oct; 27(10):1053-70. PubMed ID: 9364742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urinary metabolites of efonidipine hydrochloride in man.
    Nakabeppu H; Asada M; Oda T; Shinozaki Y; Yajima T
    Xenobiotica; 1996 Feb; 26(2):229-39. PubMed ID: 8868006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.